Abbott
add_icon

Abbott

26,960.00
+275.00
(1.03%)
Market Cap
57,288.12 Cr
PE Ratio
37.22
Volume
7,310.00
Day High - Low
27,260.00 - 26,290.00
52W High-Low
37,000.00 - 26,000.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
57,288.12 Cr
EPS
665.62
PE Ratio
37.22
PB Ratio
14.14
Book Value
1,887.49
EBITDA
1,970.20
Dividend Yield
1.78 %
Industry
Healthcare
Return on Equity
33.41
Debt to Equity
0.04
Analyst Rating and Forecast
- By Refinitiv from7 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Abbott India announces strategic partnership with Novo Nordisk India to launch Extensior and enhance access to semaglutide treatment across Indian markets.
neutral
Abbott India Limited has scheduled its Board of Directors meeting for February 12, 2026, to consider and approve unaudited financial results for Q3FY26 and nine months ended December 31, 2025.
neutral
ABB India executed a significant block trade on NSE worth Rs. 69.64 crores involving 121,882 shares at Rs. 5713.50 per share, indicating substantial institutional activity.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,801.60
#1 4,32,264.19
39.98
#1 54,729.00
9.71
#1 10,980
16.07
62.14
6,071.00
1,61,165.97
67.21
9,712.00
18.67
2,191
-1.02
38.37
4,390.00
1,48,577.55
66.21
11,539.40
6.99
1,911
26.24
61.73
1,292.30
1,07,859.28
19.93
33,741.20
16.73
5,725
-15.28
51.79
1,314.70
1,06,197.76
23.61
28,409.50
7.12
5,291
-57.18
40.42
2,314.90
1,05,744.36
23.07
22,909.50
13.74
3,306
#1 37.44
57.99
905.90
91,154.74
#1 18.35
23,511.00
18.55
4,615
-0.32
48.43
2,138.90
88,294.88
50.56
12,744.20
#1 20.90
2,007
7.65
47.71
1,296.50
75,300.93
21.89
32,345.60
9.43
3,484
7.59
66.14
5,355.50
64,033.04
26.89
13,458.30
3.70
2,216
1.90
40.57
Growth Rate
Revenue Growth
9.64 %
Net Income Growth
17.75 %
Cash Flow Change
-16.57 %
ROE
2.86 %
ROCE
-0.57 %
EBITDA Margin (Avg.)
5.63 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
2,337
2,665
2,960
3,416
3,792
4,208
4,391
4,997
5,503
6,097
6,685
7,113
Expenses
1,977
2,250
2,505
2,774
3,074
3,337
3,389
3,832
4,143
4,396
4,715
4,985
EBITDA
360
415
455
642
718
871
1,002
1,165
1,360
1,701
1,970
2,128
Operating Profit %
13 %
14 %
14 %
16 %
16 %
18 %
21 %
22 %
23 %
25 %
26 %
27 %
Depreciation
15
14
16
16
17
60
58
66
70
71
72
75
Interest
1
3
2
4
2
9
18
19
16
12
11
23
Profit Before Tax
344
398
437
622
699
803
926
1,080
1,274
1,618
1,887
2,031
Tax
115
143
160
220
249
210
235
281
324
417
473
522
Net Profit
229
255
277
401
450
593
691
799
949
1,201
1,414
1,524
EPS in ₹
107.75
120.12
130.19
188.81
211.93
279.04
325.04
375.87
446.80
565.28
665.62
717.20

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,374
1,617
2,066
2,416
2,941
3,547
3,840
4,224
4,556
5,194
5,917
Fixed Assets
96
109
110
81
105
270
251
271
237
225
336
Current Assets
1,226
1,451
1,893
2,266
2,761
3,205
3,487
3,853
3,025
3,246
4,742
Capital Work in Progress
4
3
6
2
1
2
1
1
4
10
18
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
1,274
1,505
1,950
2,333
2,835
3,275
3,589
3,953
4,315
4,958
5,563
Total Equity & Liabilities
1,374
1,617
2,066
2,416
2,941
3,547
3,840
4,224
4,556
5,194
5,917
Current Liabilities
397
382
632
668
857
891
1,031
1,203
1,206
1,343
1,407
Non Current Liabilities
39
39
47
55
75
224
207
201
161
152
277
Total Equity
938
1,196
1,387
1,693
2,009
2,432
2,602
2,820
3,189
3,699
4,233
Reserve & Surplus
916
1,174
1,366
1,672
1,987
2,411
2,581
2,799
3,167
3,678
4,212
Share Capital
21
21
21
21
21
21
21
21
21
21
21

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-30
91
62
-165
99
8
73
-86
107
52
269
Investing Activities
-187
-77
-155
-215
-257
-401
-72
-396
-148
-416
182
Operating Activities
215
249
307
153
499
626
727
948
893
1,213
1,012
Financing Activities
-58
-80
-90
-102
-143
-217
-582
-637
-639
-745
-925

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.18 %
0.18 %
0.18 %
0.16 %
0.16 %
0.16 %
0.16 %
0.16 %
0.18 %
DIIs
4.60 %
5.80 %
4.30 %
4.20 %
4.96 %
5.24 %
7.73 %
8.39 %
8.62 %
8.67 %
8.71 %
8.74 %
8.91 %
8.81 %
8.99 %
9.01 %
8.92 %
9.19 %
9.11 %
9.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
16.15 %
15.83 %
15.60 %
15.81 %
15.15 %
14.72 %
14.60 %
14.25 %
14.07 %
13.95 %
13.89 %
13.97 %
13.80 %
13.86 %
13.65 %
13.59 %
13.66 %
13.35 %
13.43 %
13.42 %
Others
4.26 %
3.38 %
5.11 %
5.01 %
4.91 %
5.06 %
2.68 %
2.37 %
2.32 %
2.39 %
2.42 %
2.13 %
2.12 %
2.16 %
2.21 %
2.25 %
2.28 %
2.31 %
2.31 %
2.42 %
No of Share Holders
0
84,478
75,540
73,417
83,236
90,567
82,113
83,526
72,086
69,582
68,885
72,252
69,382
71,588
69,449
67,892
69,934
67,584
71,199
75,801

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 40 55 65 250 275 275 325 410 475 0.00
Dividend Yield (%) 0.73 0.75 0.42 1.67 1.55 1.26 1.2 1.33 1.76 0.00

Announcements

Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 27, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 18, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2026
Unaudited Financial Results Of The Company For The Quarter Ended December 31 2025.Feb 12, 2026
Board Meeting Outcome for Outcome Of Board Meeting.Feb 12, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 04, 2026
Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.Feb 04, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 14, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 14, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2026
Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.Dec 31, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateDec 24, 2025
Closure of Trading WindowDec 19, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementNov 25, 2025
Approval Of Central Government For Appointment Of Managing DirectorNov 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 07, 2025
Unaudited Financial Results For The Quarter Ended September 30 2025.Nov 06, 2025
Board Meeting Outcome for Outcome Of Board MeetingNov 06, 2025
Board Meeting Intimation for Intimation Under Regulation 29(1)(A) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.Oct 29, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportOct 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementOct 08, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 25, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 24, 2025
Closure of Trading WindowSep 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 12, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotSep 11, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 13, 2025
Unaudited Financial Results For The Quarter Ended June 30 2025.Aug 12, 2025
Board Meeting Outcome for Outcome Of Board MeetingAug 12, 2025
Board Meeting Outcome for Outcome Of Board MeetingAug 12, 2025
Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended On June 30 2025.Aug 04, 2025
Disclosure Under Regulation 30Aug 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 29, 2025
Communication Providing The Weblink Including Path Of Annual Report.Jul 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 18, 2025
Business Responsibility and Sustainability Reporting (BRSR)Jul 18, 2025
Notice Of The 81St Annual General Meeting Of The Company.Jul 18, 2025
Reg. 34 (1) Annual Report.Jul 18, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Closure of Trading WindowJun 26, 2025
Communication To Shareholders : Intimation About Tax Deduction At Source On Dividend.Jun 18, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
Record Date For Entitlement Of DividendMay 15, 2025
Annual General Meeting On August 13 2025May 15, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 15, 2025
Results For The Financial Year Ended March 31 2025May 15, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
JioBlackRock Flexi Cap Fund Direct-Growth
0.00%
-1393
-0.15%
-0.16%
Bandhan Healthcare Fund Direct - Growth
1.98%
500
0.30%
0.32%
JioBlackRock Sector Rotation Fund Direct - Growth
0.10%
41
0.10%
0.10%
JioBlackRock Nifty Midcap 150 Index Fund Direct-Growth
0.37%
24
-0.02%
-0.03%
Tata Nifty Midcap 150 Index Fund Direct-Growth
0.37%
16
-0.02%
-0.02%
Aditya Birla Sun Life BSE 500 Quality 50 Index Fund Direct-Growth
1.13%
-10
-0.02%
-0.07%
DSP Nifty Healthcare Index Fund Direct-Growth
1.37%
9
-0.16%
-0.16%
Kotak Nifty Midcap 150 Index Fund Direct - Growth
0.37%
4
-0.01%
-0.03%
Tata BSE Quality Index Fund Direct - Growth
1.39%
3
-0.02%
-0.08%
Groww Nifty Midcap 150 Index Fund Direct - Growth
0.36%
2
0.01%
-0.03%
DSP Nifty Midcap 150 Index Fund Direct - Growth
0.38%
2
0.01%
-0.01%
Navi Nifty MidSmallcap 400 Index Fund Direct - Growth
0.24%
-1
0.00%
-0.02%
LIC MF Dividend Yield Fund Direct - Growth
1.27%
0
0.00%
1.27%
Bank of India Mid & Small Cap Equity & Debt Fund Direct-Growth
2.93%
0
0.00%
0.23%
LIC MF Multi Cap Fund Direct - Growth
1.47%
0
0.00%
0.00%
Bajaj Finserv ELSS Tax Saver Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bajaj Finserv Healthcare Fund Direct-Growth
1.46%
0
0.00%
-0.10%
Bajaj Finserv Large and Mid Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bajaj Finserv Multi Asset Allocation Fund Direct-Growth
0.75%
0
0.00%
-0.09%
Bandhan BSE Healthcare Index Fund Direct-Growth
1.03%
0
0.00%
-0.11%
Axis Nifty 500 Index Fund Direct-Growth
0.07%
0
0.00%
0.00%
Bandhan Large & Mid Cap Fund Direct-Growth
0.18%
0
0.00%
-0.03%
Mahindra Manulife Large Cap Fund Direct - Growth
0.00%
0
0.00%
-0.83%
Bandhan Multi-Factor Fund Direct - Growth
0.00%
0
0.00%
0.00%
Bandhan Nifty Midcap 150 Index Fund Direct-Growth
0.37%
0
0.00%
-0.01%

Technical Indicators

RSI(14)
Neutral
49.29
ATR(14)
Volatile
635.28
STOCH(9,6)
Neutral
41.27
STOCH RSI(14)
Neutral
46.96
MACD(12,26)
Bullish
57.05
ADX(14)
Weak Trend
19.47
UO(9)
Bearish
49.39
ROC(12)
Uptrend And Accelerating
2.26
WillR(14)
Neutral
-61.45

About Abbott

Abbott India Ltd is a leading multinational pharmaceutical company in India. It operates an owned manufacturing facility in Goa and works with various independent contract manufacturers across the country. The company sells its products primarily within India through independent distributors. Abbott India provides pharmaceutical products and solutions across various therapeutic...more
Chairperson NameMunir Shaikh